Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
Ontology highlight
ABSTRACT: RATIONALE: Genetic testing may help predict how patients will respond to chemotherapy drugs and may help doctors plan more effective treatment with fewer side effects.
PURPOSE: Genetic study to determine how genes affect the severity of diarrhea in patients with stage III colon cancer who are receiving chemotherapy.
DISEASE(S): Diarrhea,Colorectal Cancer,Neutropenia
PROVIDER: 2008449 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA